Brian Gielen

Brian advises clients on a broad range of domestic and cross-border corporate law matters, including public and private M&A, venture capital and private equity investments, as well as capital markets transactions. He advises on other general corporate law matters, such as corporate governance and corporate restructuring. He works with companies in a variety of sectors and industries.

Capital markets transactions

• Advised MDxHealth, a Belgian pharmaceuticals company, on the registered public offering for total gross proceeds of USD 43 million.

• Assisted Mithra Pharmaceuticals, a Belgian pharmaceuticals company, on the accelerated access to a new tranche of the amended loan facility concluded with funds managed by Highbridge Capital Management, LLC and funds managed by Whitebox Advisors, LLC for an amount of EUR 12,5 million.

• Advised Mithra Pharmaceuticals, a Belgian pharmaceuticals company, on a private placement for an amount of EUR 20 million in gross proceeds.

Private equity transactions

• Advised Fortino Capital Growth PE II, a Belgium-based private equity firm, on various capital increases.

• Advised Duodev 2, a Belgium-based private equity firm, on various capital increases.

• Advised Newton Biocapital II, a Belgium-based private equity firm, on various capital increases.

Public M&A transactions

• Advised Gimv NV regarding the acquisition of the stake of the Flemish Participation Company by SD Worx at a transaction value of EUR 375 million.

Private M&A transactions

• Advised Culligan International Company on its acquisition of Sip-Well NV.

Corporate advisory and reorganisation

• Advised an international pharmaceutical group on the governance aspects of their Belgian activities, including in light of a reorganisation of the group.